{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:24:25Z","timestamp":1790515465132,"version":"4.1.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["721236"],"award-info":[{"award-number":["721236"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"MICINN","doi-asserted-by":"publisher","award":["RTI2018-094052-B-100"],"award-info":[{"award-number":["RTI2018-094052-B-100"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2017\/BMD-3684 MOIR2-CM"],"award-info":[{"award-number":["S2017\/BMD-3684 MOIR2-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["CIBERdem"],"award-info":[{"award-number":["CIBERdem"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbalip.2019.158534","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T03:02:40Z","timestamp":1572318160000},"page":"158534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view"],"prefix":"10.1016","volume":"1865","author":[{"given":"Vitor","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Grajales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela M.","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0165-1781(84)90075-1","article-title":"Positive and negative symptoms in schizophrenia","volume":"13","author":"Rosen","year":"1984","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbalip.2019.158534_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2018.08.018","article-title":"Positive and negative symptoms in schizophrenia: a longitudinal analysis using latent variable structural equation modelling","volume":"204","author":"Carra","year":"2019","journal-title":"Schizophr. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.bbalip.2019.158534_bb0015","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/schbul\/sbu006","article-title":"Schizophrenia\u2014time to commit to policy change","volume":"40","author":"Fleischhacker","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.bbalip.2019.158534_bb0020","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel","year":"2014","journal-title":"P T."},{"issue":"9","key":"10.1016\/j.bbalip.2019.158534_bb0025","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.bbalip.2019.158534_bb0030","first-page":"47","article-title":"The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbalip.2019.158534_bb0035","doi-asserted-by":"crossref","first-page":"259349","DOI":"10.1155\/2012\/259349","article-title":"Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders","volume":"2012","author":"Shen","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"9929","key":"10.1016\/j.bbalip.2019.158534_bb0040","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","article-title":"Schizophrenia: an integrated sociodevelopmental-cognitive model","volume":"383","author":"Howes","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/oxfordjournals.schbul.a033325","article-title":"Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters","volume":"24","author":"O\u2019Donnell","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.bbalip.2019.158534_bb0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.biopsych.2013.11.023","article-title":"Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition","volume":"76","author":"Simpson","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2337\/diacare.29.04.06.dc05-1261","article-title":"Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders","volume":"29","author":"Cohen","year":"2006","journal-title":"Diabetes Care"},{"issue":"Suppl. 18","key":"10.1016\/j.bbalip.2019.158534_bb0065","first-page":"27","article-title":"Dyslipidemia and atypical antipsychotic drugs","volume":"65","author":"Casey","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 7","key":"10.1016\/j.bbalip.2019.158534_bb0070","first-page":"32","article-title":"The clinical implications of weight gain in schizophrenia","volume":"62","author":"Kurzthaler","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12445","article-title":"Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management","volume":"132","author":"Manu","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0080","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1530\/JOE-16-0211","article-title":"Adipose tissue in control of metabolism","volume":"231","author":"Luo","year":"2016","journal-title":"J. Endocrinol."},{"issue":"Pt 5","key":"10.1016\/j.bbalip.2019.158534_bb0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1042\/BST0360935","article-title":"Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese","volume":"36","author":"Tan","year":"2008","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrendo.2016.211","article-title":"Adipose tissue in 2016: advances in the understanding of adipose tissue biology","volume":"13","author":"Kajimura","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7207","key":"10.1016\/j.bbalip.2019.158534_bb0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature07182","article-title":"PRDM16 controls a brown fat\/skeletal muscle switch","volume":"454","author":"Seale","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbalip.2019.158534_bb0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/dvg.20630","article-title":"Inducible lineage tracing of Pax7-descendant cells reveals embryonic origin of adult satellite cells","volume":"48","author":"Lepper","year":"2010","journal-title":"Genesis"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.1700910126","article-title":"Brown adipose tissue and heat production in the newborn infant","volume":"91","author":"Aherne","year":"1966","journal-title":"J. Pathol. Bacteriol."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2012.09.010","article-title":"Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria","volume":"151","author":"Fedorenko","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0120","doi-asserted-by":"crossref","first-page":"E444","DOI":"10.1152\/ajpendo.00691.2006","article-title":"Unexpected evidence for active brown adipose tissue in adult humans","volume":"293","author":"Nedergaard","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.bbalip.2019.158534_bb0125","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbalip.2019.158534_bb0130","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1096\/fj.09-133546","article-title":"The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue","volume":"23","author":"Zingaretti","year":"2009","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0014-5793(84)80822-4","article-title":"Brown adipose tissue in the parametrial fat pad of the mouse","volume":"167","author":"Young","year":"1984","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.bbalip.2019.158534_bb0145","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bbalip.2019.158534_bb0150","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1074\/jbc.M109.053942","volume":"285","author":"Petrovic","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0155","doi-asserted-by":"crossref","first-page":"C670","DOI":"10.1152\/ajpcell.2000.279.3.C670","article-title":"Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes","volume":"279","author":"Himms-Hagen","year":"2000","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0160","doi-asserted-by":"crossref","first-page":"E1244","DOI":"10.1152\/ajpendo.00600.2009","article-title":"The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation","volume":"298","author":"Barbatelli","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/phy2.15","article-title":"Subcutaneous adipose tissue transplantation in diet-induced obese mice attenuates metabolic dysregulation while removal exacerbates it","volume":"1","author":"Foster","year":"2013","journal-title":"Physiol. Rep."},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/joim.12540","article-title":"Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids","volume":"280","author":"Smith","year":"2016","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eurpsy.2009.01.001","article-title":"How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins","volume":"24","author":"Starrenburg","year":"2009","journal-title":"Eur Psychiatry"},{"issue":"7","key":"10.1016\/j.bbalip.2019.158534_bb0180","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004754","article-title":"Regulation of cholesterol and fatty acid synthesis","volume":"3","author":"Ye","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0190","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1038\/s41598-017-11323-9","article-title":"Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.bbalip.2019.158534_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-006-9160-4","article-title":"SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?","volume":"289","author":"Raeder","year":"2006","journal-title":"Mol .Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbr.2009.09.032","article-title":"Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance","volume":"207","author":"Guesdon","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.bbalip.2019.158534_bb0210","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.1714-04.2005","article-title":"The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance","volume":"25","author":"Georgescu","year":"2005","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0215","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cell.2011.09.045","article-title":"A conserved SREBP-1\/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans","volume":"147","author":"Walker","year":"2011","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bbalip.2019.158534_bb0220","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1073\/pnas.162488899","article-title":"Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins","volume":"99","author":"Yabe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/tpj.2010.74","article-title":"Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics","volume":"12","author":"Liou","year":"2012","journal-title":"Pharmacogenomics J."},{"issue":"13","key":"10.1016\/j.bbalip.2019.158534_bb0230","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1073\/pnas.0400356101","article-title":"Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse","volume":"101","author":"Imai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbalip.2019.158534_bb0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010124","article-title":"Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules","volume":"17","author":"Moseti","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0245","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.pnpbp.2011.07.017","article-title":"Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism","volume":"35","author":"Sertie","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"11","key":"10.1016\/j.bbalip.2019.158534_bb0250","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.mp.4001892","article-title":"Clozapine enhances differentiation of adipocyte progenitor cells","volume":"11","author":"Hemmrich","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2019.158534_bb0255","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.bbalip.2019.158534_bb0260","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/cn5002107","article-title":"Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating PPARgamma","volume":"6","author":"Wang","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0270","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/tpj.2009.67","article-title":"Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-beta","volume":"10","author":"Pavan","year":"2010","journal-title":"Pharmacogenomics J."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0275","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbrc.2015.10.045","article-title":"Olanzapine promotes the accumulation of lipid droplets and the expression of multiple perilipins in human adipocytes","volume":"467","author":"Nimura","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bbalip.2019.158534_bb0280","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1074\/jbc.M800055200","article-title":"Transcriptional regulation of fatty acid translocase\/CD36 expression by CCAAT\/enhancer-binding protein alpha","volume":"283","author":"Qiao","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0285","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2015.08.055","article-title":"Fatty acid transport protein-2 inhibitor Grassofermata\/CB5 protects cells against lipid accumulation and toxicity","volume":"465","author":"Saini","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7640","key":"10.1016\/j.bbalip.2019.158534_bb0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"issue":"Suppl. 7","key":"10.1016\/j.bbalip.2019.158534_bb0295","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/ijo.2008.233","article-title":"Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases","volume":"32","author":"Yamauchi","year":"2008","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0305","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"Sarvari","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jphs.2017.01.004","article-title":"Effects of clozapine on adipokine secretions\/productions and lipid droplets in 3T3-L1 adipocytes","volume":"133","author":"Tsubai","year":"2017","journal-title":"J. Pharmacol. Sci."},{"issue":"6704","key":"10.1016\/j.bbalip.2019.158534_bb0315","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bbalip.2019.158534_bb0320","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"issue":"5581","key":"10.1016\/j.bbalip.2019.158534_bb0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","article-title":"Activation of central melanocortin pathways by fenfluramine","volume":"297","author":"Heisler","year":"2002","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.bbalip.2019.158534_bb0330","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1073\/pnas.88.24.11515","article-title":"Expression cloning of a cDNA encoding the bovine histamine H1 receptor","volume":"88","author":"Yamashita","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0335","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40263-013-0062-1","article-title":"The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain","volume":"27","author":"He","year":"2013","journal-title":"CNS Drugs"},{"issue":"6522","key":"10.1016\/j.bbalip.2019.158534_bb0340","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0345","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0899-9007(97)91277-6","article-title":"Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism","volume":"13","author":"Sakata","year":"1997","journal-title":"Nutrition"},{"key":"10.1016\/j.bbalip.2019.158534_bb0350","first-page":"139239","article-title":"Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines","volume":"2013","author":"Makki","year":"2013","journal-title":"ISRN Inflamm."},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0355","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/diacare.26.8.2383","article-title":"Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity","volume":"26","author":"Ryan","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0360","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182524393","article-title":"Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia","volume":"32","author":"Sugai","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2013.06.317","article-title":"Adiponectin in inflammatory and immune-mediated diseases","volume":"64","author":"Fantuzzi","year":"2013","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/cc10021","article-title":"Clinical review: adiponectin biology and its role in inflammation and critical illness","volume":"15","author":"Robinson","year":"2011","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cyto.2011.10.001","article-title":"Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-\u03baB pathway in 3T3-L1 adipocytes","volume":"57","author":"Lira","year":"2012","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0380","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/db16-1167","article-title":"Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio metabolism study","volume":"66","author":"Gastaldelli","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0385","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14656566.6.2.337","article-title":"Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness","volume":"6","author":"Harvey","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0390","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(98)00300-3","article-title":"Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system","volume":"105","author":"Hunter","year":"1998","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.bbalip.2019.158534_bb0395","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00125-008-1152-3","article-title":"Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat","volume":"51","author":"Smith","year":"2008","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pnpbp.2005.06.008","article-title":"At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes","volume":"30","author":"Robinson","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0405","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0410","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S1516-44462012000200009","article-title":"Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine","volume":"34","author":"Zugno","year":"2012","journal-title":"Braz. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0415","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/026988110201600402","article-title":"Characterization of olanzapine-induced weight gain in rats","volume":"16","author":"Goudie","year":"2002","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1590\/1516-4446-2012-1052","article-title":"Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics","volume":"35","author":"Volpato","year":"2013","journal-title":"Braz. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030640","article-title":"Olanzapine induced dysmetabolic changes involving tissue chromium mobilization in female rats","volume":"20","author":"Yang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(03)00042-X","article-title":"Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human","volume":"75","author":"Pouzet","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbalip.2019.158534_bb0435","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.psyneuen.2016.07.218","article-title":"Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats","volume":"73","author":"Horska","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0440","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.pnpbp.2010.06.002","article-title":"Induction of subcutaneous adipose proliferation by olanzapine in rodents","volume":"34","author":"Tan","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0445","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.mp.4001948","article-title":"Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment","volume":"12","author":"Minet-Ringuet","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0450","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.mp.4000581","article-title":"Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia","volume":"4","author":"Duncan","year":"1999","journal-title":"Mol. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.bbalip.2019.158534_bb0455","first-page":"507S","article-title":"Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation","volume":"3","author":"Lafontan","year":"1995","journal-title":"Obes. Res."},{"key":"10.1016\/j.bbalip.2019.158534_bb0460","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.05.060","article-title":"Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state","volume":"1350","author":"Victoriano","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2019.158534_bb0465","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psyneuen.2018.05.021","article-title":"Effects of chronic antipsychotic drug exposure on the expression of translocator protein and inflammatory markers in rat adipose tissue","volume":"95","author":"Calevro","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"46","key":"10.1016\/j.bbalip.2019.158534_bb0470","doi-asserted-by":"crossref","first-page":"45777","DOI":"10.1074\/jbc.M301977200","article-title":"Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects","volume":"278","author":"Rotter","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0475","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41598-018-36930-y","article-title":"Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbalip.2019.158534_bb0480","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0269881114555250","article-title":"Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female rats","volume":"28","author":"Zhang","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0485","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.bbalip.2019.158534_bb0490","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbalip.2019.158534_bb0495","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1172\/JCI93090","article-title":"Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy","volume":"128","author":"Cui","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0500","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/jpet.108.137240","volume":"326","author":"Coccurello","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0505","first-page":"495","article-title":"Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL\/6J mice","volume":"21","author":"Hou","year":"2018","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.bbalip.2019.158534_bb0510","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fphar.2018.00379","article-title":"The Wnt signaling pathway effector TCF7L2 mediates olanzapine-induced weight gain and insulin resistance","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0515","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","volume":"16","author":"Albaugh","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbalip.2019.158534_bb0520","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bcp.2018.10.001","article-title":"Regulation of obesity-associated metabolic disturbance by the antipsychotic drug olanzapine: role of the autophagy-lysosome pathway","volume":"158","author":"Zhang","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bbalip.2019.158534_bb0525","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.regpep.2009.05.002","article-title":"The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha","volume":"157","author":"Kunnari","year":"2009","journal-title":"Regul. Pept."},{"issue":"7","key":"10.1016\/j.bbalip.2019.158534_bb0530","first-page":"259","article-title":"Human resistin: found in translation from mouse to man","volume":"22","author":"Schwartz","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08039488.2016.1230649","article-title":"Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine","volume":"71","author":"Klemettila","year":"2017","journal-title":"Nord. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.bbalip.2019.158534_bb0540","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.schres.2016.04.051","article-title":"Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics","volume":"174","author":"Sapra","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0545","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2011.03.010","article-title":"Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study","volume":"22","author":"Wampers","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0550","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000218404.64619.52","article-title":"Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia","volume":"26","author":"Richards","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0555","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/070674370605100608","article-title":"Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report","volume":"51","author":"Cohn","year":"2006","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0560","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jc.2007-1167","article-title":"Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism","volume":"93","author":"van Nimwegen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.bbalip.2019.158534_bb0565","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","article-title":"Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes","volume":"280","author":"Xu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.158534_bb0570","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-244X-13-146","article-title":"Levels of S100B are raised in female patients with schizophrenia","volume":"13","author":"O'Connell","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbalip.2019.158534_bb0575","first-page":"480707","article-title":"S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance","author":"Steiner","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0580","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/mol.108.044925","article-title":"Novel interaction of the dopamine D2 receptor and the Ca2+ binding protein S100B: role in D2 receptor function","volume":"74","author":"Liu","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0585","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/JCP.0b013e31829e8333","article-title":"Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls","volume":"33","author":"Hahn","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0590","first-page":"626","article-title":"Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue","volume":"83","author":"Samra","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bbalip.2019.158534_bb0595","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.08m04654yel","article-title":"Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study","volume":"71","author":"Vidarsdottir","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0600","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/oby.2010.6","article-title":"Increased food intake and energy expenditure following administration of olanzapine to healthy men","volume":"18","author":"Fountaine","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0605","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamapsychiatry.2018.1088","article-title":"Metabolic effects of antipsychotics on adiposity and insulin sensitivity in youths: a randomized clinical trial","volume":"75","author":"Nicol","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0610","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/0269881113509904","article-title":"The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study","volume":"28","author":"Taveira","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0615","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cmet.2010.03.005","article-title":"Transcriptional control of brown fat development","volume":"11","author":"Kajimura","year":"2010","journal-title":"Cell Metab."},{"issue":"7259","key":"10.1016\/j.bbalip.2019.158534_bb0620","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nature08262","article-title":"Initiation of myoblast to brown fat switch by a PRDM16-C\/EBP-beta transcriptional complex","volume":"460","author":"Kajimura","year":"2009","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bbalip.2019.158534_bb0625","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0630","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cmet.2011.06.012","article-title":"Different metabolic responses of human brown adipose tissue to activation by cold and insulin","volume":"14","author":"Orava","year":"2011","journal-title":"Cell Metab."},{"issue":"7207","key":"10.1016\/j.bbalip.2019.158534_bb0635","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature07221","article-title":"New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure","volume":"454","author":"Tseng","year":"2008","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbalip.2019.158534_bb0640","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/oby.2003.163","article-title":"Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance","volume":"11","author":"Yang","year":"2003","journal-title":"Obes. Res."},{"issue":"9","key":"10.1016\/j.bbalip.2019.158534_bb0645","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3858\/emm.2012.44.9.062","article-title":"Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics","volume":"44","author":"Oh","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0650","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1389557053175380","article-title":"The brown adipose cell: a unique model for understanding the molecular mechanism of insulin resistance","volume":"5","author":"Valverde","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0655","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1440-1681.2005.04184.x","article-title":"Resistance to excessive bodyweight gain in risperidone-injected rats","volume":"32","author":"Ota","year":"2005","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbalip.2019.158534_bb0660","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pnpbp.2014.02.003","article-title":"Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats","volume":"51","author":"Zhang","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0665","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cell.2018.10.016","article-title":"Secretin-activated brown fat mediates prandial thermogenesis to induce satiation","volume":"175","author":"Li","year":"2018","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.bbalip.2019.158534_bb0670","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0675","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1113\/EP085642","article-title":"Brown adipose tissue activation as measured by infrared thermography by mild anticipatory psychological stress in lean healthy females","volume":"101","author":"Robinson","year":"2016","journal-title":"Exp. Physiol."},{"issue":"21","key":"10.1016\/j.bbalip.2019.158534_bb0680","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00213-017-4710-x","article-title":"Clozapine, chlorpromazine and risperidone dose-dependently reduce emotional hyperthermia, a biological marker of salience","volume":"234","author":"Blessing","year":"2017","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0685","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01369-4","article-title":"Acute effects of antipsychotic drugs on cardiovascular responses to stress","volume":"464","author":"van den Buuse","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0690","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0022-3565(25)23018-X","article-title":"Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat","volume":"256","author":"Swerdlow","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.bbalip.2019.158534_bb0695","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbalip.2019.158534_bb0700","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3565(25)26870-7","article-title":"The influence of chlorpromazine on physical and chemical mechanisms of temperature regulation in the rat","volume":"145","author":"Kollias","year":"1964","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0705","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130050741","article-title":"Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats","volume":"140","author":"Swerdlow","year":"1998","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0710","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0091-3057(88)90084-6","article-title":"Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats","volume":"30","author":"Chipkin","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0715","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pnpbp.2006.09.005","article-title":"Activation of dopamine D2 receptors in the CNS inhibits sympathetic cutaneous vasomotor alerting responses (SCVARs), contributing to clozapine\u2019s SCVAR-inhibiting action","volume":"31","author":"Blessing","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0720","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/j.2040-4603.2014.tb00592.x","article-title":"Central nervous system regulation of brown adipose tissue","volume":"4","author":"Morrison","year":"2014","journal-title":"Compr. Physiol."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0725","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/j.2040-4603.2016.tb00711.x","article-title":"Control of the cutaneous circulation by the central nervous system","volume":"6","author":"Blessing","year":"2016","journal-title":"Compr. Physiol."},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0730","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.4701-12.2013","article-title":"alpha2 Adrenergic receptor-mediated inhibition of thermogenesis","volume":"33","author":"Madden.","year":"2013","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0735","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13204","article-title":"The histaminergic system is involved in psychological stress-induced hyperthermia in rats","volume":"5","author":"Lkhagvasuren","year":"2017","journal-title":"Physiol. Rep."},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0740","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.euroneuro.2015.03.002","article-title":"Olanzapine depot exposure in male rats: dose-dependent lipogenic effects without concomitant weight gain","volume":"25","author":"Ferno","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0745","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145713000862","article-title":"Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects","volume":"17","author":"Skrede","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0750","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/oby.2008.468","article-title":"The role of thermogenesis in antipsychotic drug-induced weight gain","volume":"17","author":"Stefanidis","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0755","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0760","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0306-4522(01)00555-3","article-title":"The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat","volume":"110","author":"Oldfield","year":"2002","journal-title":"Neuroscience"},{"issue":"15","key":"10.1016\/j.bbalip.2019.158534_bb0765","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1523\/JNEUROSCI.22-15-06742.2002","article-title":"Differential activation of orexin neurons by antipsychotic drugs associated with weight gain","volume":"22","author":"Fadel","year":"2002","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0770","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1460-9568.2007.05429.x","article-title":"Lateral hypothalamic \u2018command neurons\u2019 with axonal projections to regions involved in both feeding and thermogenesis","volume":"25","author":"Oldfield","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0775","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cne.903150307","article-title":"Functional and anatomical organization of cardiovascular pressor and depressor sites in the lateral hypothalamic area: I. Descending projections","volume":"315","author":"Allen","year":"1992","journal-title":"J. Comp. Neurol."},{"issue":"7755","key":"10.1016\/j.bbalip.2019.158534_bb0780","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-019-1156-9","article-title":"Innervation of thermogenic adipose tissue via a calsyntenin 3beta-S100b axis","volume":"569","author":"Zeng","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbalip.2019.158534_bb0785","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","article-title":"S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles","volume":"33","author":"Donato","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0790","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/joim.12803","article-title":"Inflammation of brown\/beige adipose tissues in obesity and metabolic disease","volume":"284","author":"Villarroya","year":"2018","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0795","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.physbeh.2008.11.011","article-title":"Risperidone alters food intake, core body temperature, and locomotor activity in mice","volume":"96","author":"Cope","year":"2009","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0800","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.appet.2006.01.008","article-title":"Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration","volume":"46","author":"Minet-Ringuet","year":"2006","journal-title":"Appetite"},{"issue":"8","key":"10.1016\/j.bbalip.2019.158534_bb0805","doi-asserted-by":"crossref","first-page":"e104160","DOI":"10.1371\/journal.pone.0104160","article-title":"Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment","volume":"9","author":"Lian","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0810","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cmet.2017.06.014","article-title":"Hypothalamic AMPK-ER stress-JNK1 axis mediates the central actions of thyroid hormones on energy balance","volume":"26","author":"Martinez-Sanchez","year":"2017","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bbalip.2019.158534_bb0815","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/en.2015-1099","article-title":"Propranolol attenuates risperidone-induced trabecular bone loss in female mice","volume":"156","author":"Motyl","year":"2015","journal-title":"Endocrinology"},{"issue":"6549","key":"10.1016\/j.bbalip.2019.158534_bb0820","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/377527a0","article-title":"Transient increase in obese gene expression after food intake or insulin administration","volume":"377","author":"Saladin","year":"1995","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbalip.2019.158534_bb0825","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3892\/ijmm.2016.2542","article-title":"Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K\/Akt\/mTOR and AMPK pathways","volume":"37","author":"Cui","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.bbalip.2019.158534_bb0830","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1258\/ebm.2011.011143","article-title":"Possible involvement of uncoupling protein 1 in appetite control by leptin","volume":"236","author":"Okamatsu-Ogura","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0835","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00004714-200208000-00015","article-title":"Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment","volume":"22","author":"Monteleone","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbalip.2019.158534_bb0840","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/en.2010-0659","article-title":"Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion","volume":"152","author":"Arruda","year":"2011","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.bbalip.2019.158534_bb0845","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1038\/tp.2016.230","article-title":"Clozapine modifies the differentiation program of human adipocytes inducing browning","volume":"6","author":"Kristof","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0850","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0893-133X(02)00314-7","article-title":"Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo","volume":"27","author":"Elman","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0855","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.301.1.197","article-title":"Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain","volume":"301","author":"Dwivedi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0860","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis","volume":"21","author":"Crane","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2019.158534_bb0865","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1038\/ncomms7794","article-title":"Regulation of systemic energy homeostasis by serotonin in adipose tissues","volume":"6","author":"Oh","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbalip.2019.158534_bb0870","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/pr100892r","article-title":"Metabolomic analysis of livers and serum from high-fat diet induced obese mice","volume":"10","author":"Kim","year":"2011","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.bbalip.2019.158534_bb0875","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/oby.2011.253","article-title":"Association of variations in TPH1 and HTR2B with gestational weight gain and measures of obesity","volume":"20","author":"Kwak","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbalip.2019.158534_bb0880","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1038\/ncomms10895","article-title":"The Gq signalling pathway inhibits brown and beige adipose tissue","volume":"7","author":"Klepac","year":"2016","journal-title":"Nat. Commun."},{"issue":"Suppl. 2","key":"10.1016\/j.bbalip.2019.158534_bb0885","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics","volume":"25","author":"Correll","year":"2010","journal-title":"Eur. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbalip.2019.158534_bb0890","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.bjp.0705530","article-title":"Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor","volume":"140","author":"Buckland","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbalip.2019.158534_bb0895","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/jpet.105.087965","article-title":"Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist","volume":"314","author":"Lim","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2019.158534_bb0900","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00131.2019","article-title":"Stimulation of histamine H4 receptor participates in cold-induced browning of subcutaneous white adipose tissue","author":"Zhao","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198119301854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198119301854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:05:59Z","timestamp":1761386759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198119301854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":180,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1388198119301854"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2019.158534","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2019.158534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"158534"}}